Ondansetron Tablet, Orally Disintegrating
Product Images NDC 83980-012

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 83980-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ipca Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (E887abe7 4443 4b77 8e84 4c7cc0098e94 01)

Chemical structure of Ondansetron, showing its molecular framework including a fused bicyclic ring and a substituted imidazole ring.*

FDA Label Image

Mm3 (E887abe7 4443 4b77 8e84 4c7cc0098e94 02)

Ondansetron Orally Disintegrating Tablets, USP 4 mg in a 30-tablet quantity. The label shows the Ipca Laboratories Limited logo and instructions for storage and dispensing. It includes a phenylketonurics warning, Rx only designation, barcode, and distributor information for Unichem Pharmaceuticals (USA), Inc.*

FDA Label Image

Mm6 (E887abe7 4443 4b77 8e84 4c7cc0098e94 03)

Ondansetron Orally Disintegrating Tablets USP 8 mg, with a package containing 30 tablets. The label includes usage instructions, storage conditions, a barcode, and distributor information for Unichem Pharmaceuticals (USA), Inc. The product is made in India and labeled by Ipca Laboratories Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.